Chargement en cours...
Luteolin as a therapeutic option for multiple sclerosis
Multiple sclerosis (MS) remains without an effective treatment in spite of intense research efforts. Interferon-beta (IFN-β) reduces duration and severity of symptoms in many relapsing-remitting MS patients, but its mechanism of action is still not well understood. Moreover, IFN-β and other availabl...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2768692/ https://ncbi.nlm.nih.gov/pubmed/19825165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-2094-6-29 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|